NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 36 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $48,000 | -5.9% | 28,465 | 0.0% | 0.00% | – |
| Q2 2021 | $51,000 | +54.5% | 28,465 | +84.1% | 0.00% | – |
| Q1 2021 | $33,000 | -58.2% | 15,465 | -57.1% | 0.00% | – |
| Q4 2020 | $79,000 | -6.0% | 36,065 | +14.1% | 0.00% | – |
| Q3 2020 | $84,000 | -22.9% | 31,615 | +14.8% | 0.00% | -100.0% |
| Q2 2020 | $109,000 | +738.5% | 27,540 | +82.5% | 0.00% | – |
| Q1 2020 | $13,000 | -27.8% | 15,090 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | +63.6% | 15,090 | +15.3% | 0.00% | – |
| Q3 2019 | $11,000 | +120.0% | 13,090 | -0.4% | 0.00% | – |
| Q2 2019 | $5,000 | – | 13,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 36,838 | $26,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,440 | $74,000 | 0.00% |
| PDS Planning, Inc | 10,565 | $8,000 | 0.00% |
| UBS Group AG | 105 | $0 | 0.00% |
| Parallel Advisors, LLC | 350 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,722 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,954 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 39,414 | $28,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 227,452 | $164,000 | 0.00% |